The largest database of trusted experimental protocols

10 protocols using z fr amc

1

Inhibition of Legumain, Papain, and Cathepsin S

Check if the same lab product or an alternative is used in the 5 most similar protocols
Inhibition of WT legumain was tested in legumain assay buffer (50 mm citric acid, pH 5.5, 100 mm NaCl) containing 100 μm benzyloxycarbonyl-Ala-Ala-Asn-7-amino-4-methylcoumarin substrate (Z-AAN-AMC; Bachem). Assays were carried out in an Infinite M200 plate reader (Tecan). Briefly, the assay buffer was preincubated with 8 nm cystatin, followed by the addition of 4 nm legumain. Increase in fluorescence was measured at 460 nm upon excitation at 380 nm at 37 °C. Inhibition of papain (EC 3.4.22.2; Merck, Darmstadt, Germany) and recombinant human cathepsin S was assayed in the same assay buffer containing 100 μm Z-FR-AMC (Bachem). The assay buffer was preincubated with 100 nm cystatin, followed by the addition of 50 nm papain or cathepsin S, and fluorescence was similarly recorded at 460 nm. Dimeric cystatin E was prepared by incubation of monomeric cystatin E at 80 °C for 10 min. The sample was filtered to remove higher oligomers. Similarly, glycosylated cystatin E was also incubated at 80 °C for 10 min to generate the dimeric form. All experiments were carried out in triplicate.
+ Open protocol
+ Expand
2

Planarian Protease Activity Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
To measure protease activity of worm lysates, planarians were ground with mortar and pestle for thirty seconds and incubated with lysis buffer (100mM Tris pH 7.5, 200mM NaCl, 1% NP-40, 0.1% SDS, 1XTBS) for one hour on ice with occasional vortexing. Samples were spun in a microcentrifuge at maximum speed, 4°C for twenty minutes. The supernatant was saved and activity was measured by adding assay mix (5mMDTT, 50mM sodium citrate, pH5.5) containing 50μM fluorescent peptide, either Z-FR-AMC or Z-RR-AMC (BACHEM). Fluorescence was measured (excitation 360nm, absorbance 460nm) using a FlexStation fluorometer (Molecular Devices) and SoftMax Pro 4.8 software. Both kinetic and endpoint assays were used. Chemical inhibitors of cathepsin B, K11777 (UCSF, CDIPD) and CA-074 (Sigma), were added at 50μM concentration two hours prior to addition of fluorescent peptides for select experiments. Protease activity was also measured with activity-based probes DCG-04 and BMV109, both gifts from Matthew Bogyo [31 (link), 32 (link)]. Probes were added to 1μM final volume in samples containing 5mM DTT, pH 5.5 for 1 hour at 37°C before imaging Cy5 levels via Typhoon Trio (GE Healthcare Life Sciences).
+ Open protocol
+ Expand
3

Leaf Protein Inhibition of Papain Activity

Check if the same lab product or an alternative is used in the 5 most similar protocols
The inhibitory activity of leaf protein extracts against commercial papain (Sigma-Aldrich, St. Louis, MO, USA)) was determined using the fluorogenic substrate Z-FR-AMC (N-carbobenzoxy-Phe-Arg-AMC, Bachem AG, Bubenddorf, Switzerland). Different extract quantities plus 10 ng of papain were incubated at room temperature in a buffer containing 100 mM sodium phosphate pH 6.0, 10 mM l-cysteine, 10 mM EDTA and 0.01% (v/v) Brij35. Then, the substrate was added and the reactions incubated for 1 h at 28 °C. Emitted fluorescence was measured with a 365 nm excitation and a 465 nm emission wavelength filter. Triplicate assays were performed for determination of each value and the average was calculated. Blanks were used to account for spontaneous breakdown of substrate and results were expressed as percentage of papain activity inhibition.
+ Open protocol
+ Expand
4

Recombinant Cathepsin K Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
Recombinant human cathepsin K was prepared as described previously [24] . Chemical probes were obtained from the U.S. NCI/DTP Open Chemical Repository or from ChemBridge (USA). Information on their identity and origin is given in Table 1. All compounds were soluble in aqueous buffers at concentrations of at least 2 mM, except for compound 2, which was soluble up to a maximal concentration of 1 mM. Stock solutions of all compounds were prepared in DMSO. The fluorogenic substrate Z-FR↓AMC (benzyloxycarbonyl-Phe-Arg-7-amino-4-methylcoumarin) was from Bachem (Switzerland).
+ Open protocol
+ Expand
5

Protease Activity Modulation by Bet v 1 Ligands

Check if the same lab product or an alternative is used in the 5 most similar protocols
To evaluate the influence of Bet v 1 ligands on cathepsin S and legumain activities, 10 nM of protease was incubated with 100 μM of ligand (unless otherwise stated) and 50 μM of fluorogenic substrate in digestion buffer (0.1 M sodium acetate pH 5.0, 0.1 M sodium chloride, 5 mM EDTA, and 2 mM DTT), as described in the online supporting information. The effect of birch pollen extract (BPE) (20–200 μg/mL) on the cathepsin S and legumain activities was assessed in parallel. The inhibitory effect of PPE1 was assessed by replacing DTT with 0.5 mM TCEP. Activities of recombinant rat cathepsin B (provided by Dr. Lukas Mach) and papain (Merck, Vienna, Austria) at 10 nM were assayed using Z-FR-AMC (Bachem) as a fluorogenic substrate.
+ Open protocol
+ Expand
6

Bet_v_1 Ligands Modulate Cathepsin S and Legumain

Check if the same lab product or an alternative is used in the 5 most similar protocols
To evaluate the influence of Bet_v_1 ligands on cathepsin S and legumain activities, 10 nmol/L of protease was incubated with 100 µmol/L of ligand (unless otherwise stated) and 50 µmol/L of fluorogenic substrate in digestion buffer (0.1 mol/L sodium acetate pH 5.0, 0.1 mol/L sodium chloride, 5 mmol/L EDTA, and 2 mmol/L DTT), as described in the Appendix [Link], [Link]. The effect of birch pollen extract (BPE) (20‐200 µg/mL) on the cathepsin S and legumain activities was assessed in parallel. The inhibitory effect of PPE1 was assessed by replacing DTT with 0.5 mmol/L TCEP. Activities of recombinant rat cathepsin B (provided by Dr Lukas Mach) and papain (Merck) at 10 nmol/L were assayed using Z‐FR‐AMC (Bachem) as a fluorogenic substrate.
+ Open protocol
+ Expand
7

Recombinant HvPAP14 Activation Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
The sequences encoding mature HvPAP14 and maltose-binding protein (MBP) were fused and inserted into the vector pMAL-c5X. Cloning, expression in Escherichia coli, and protein purification were done by using the pMAL™ Protein Fusion and Purification System (NEB, Frankfurt am Main, Germany).
The activation of HvPAP14 was measured in pH buffer (200 mM NaCl, 1 mM EDTA, 20 mM HEPES, 20 mM MES, 20 mM Tris, 20 mM sodium acetate, pH 3.5–9) with the fluorescing substrate Z-FR-AMC (20 µM) (Bachem, Bubendorf, Switzerland). The substrate turnover was analysed ratiometrically using the emission at 440 nm and 393 nm after excitation at 345 nm. For the activity measurements, HvPAP14 was activated in a buffer with a pH of 4.5 and then incubated in a 10-fold volume of pH buffer (pH 3.5–9) with Z-FR-AMC (final concentration 20 µM).
+ Open protocol
+ Expand
8

Cruzipain Inhibition Assay Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
Triton X-100, sodium acetate, DMSO, DTT (dithiothreitol) and E-64 (trans-epoxysuccinyl-L-leucylamido-(4-guanidino)butane) were purchased from Sigma-Aldrich. The Cruzipain model fluorogenic substrate Z-FR-AMC (benzyloxycarbonyl-phenylalanylarginine-4-methylcoumaryl-7-amide) was from Bachem (Bubendorf, Switzerland). Black solid bottom polystyrene Corning® NBS 384-well plates were from Sigma-Aldrich (CLS3654-100EA).
+ Open protocol
+ Expand
9

Proteases and Peptide Cleavage Assays

Check if the same lab product or an alternative is used in the 5 most similar protocols
Human recombinant proteases (with catalogue numbers indicated)
were obtained from R&D Systems (Minneapolis, MN), consisting of
human recombinant cathepsin L (#952-CY-010), human recombinant cathepsin
V (#1080-CY-010), human recombinant PC1/3 (#2810-SE-010), and human
recombinant PC2 (#6018-SE-010). Protease MSP-MS assays utilized the
library of 228 14-mer peptides designed to contain all possible protease
cleavage sites, as previously described29 (link),30 (link) (peptides
synthesized by Anaspec, Fremont, CA). Assays utilized octyl-β-glucopyranoside
(Sigma-Aldrich, Darmstadt, Germany), dithiothreitol (DTT, Promega,
Madison, WI), BEH C18 packing material (Waters Corporation, Milford,
MA), acetonitrile (ACN, Fisher Chemical, Pittsburgh, PA), trifluoroacetic
acid (TFA, Fisher Chemical, Pittsburgh, PA), urea (Teknova, Hollister,
CA), and C18 for solid-phase extraction (SPE) stage-tips (3M, Maplewood,
MN). Fluorogenic proteolytic assays used the substrates Z-K-R-AMC,
Z-R-K-AMC, Z-K-K-AMC, Z-R-R-AMC, Z-L-K-R-AMC, Z-W-K-R-AMC, Z-F-K-R-AMC,
Z-Y-K-R-AMC, Z-V-K-R-AMC, Z-G-K-R-AMC, and Z-A-K-R-AMC from Genscript
(Piscataway, NH); Z-F-R-AMC was from Bachem (Vista, CA) and pERTKR-AMC
was from R&D Systems.
+ Open protocol
+ Expand
10

Kinetic Assay of Parasite Proteases

Check if the same lab product or an alternative is used in the 5 most similar protocols
Proteolytic activities were measured in a kinetic continuous assay using the following peptidyl fluorogenic, 7-amino-4-methylcoumarin (AMC) substrates (Bachem) at a 50 µM final concentration: Z-F-R-AMC (Z, Benzyloxycarbonyl), Bz-F-V-R-AMC (Bz, Benzoyl), Z-G-P-R-AMC, P-F-R-AMC, Boc-L-R-R-AMC (Boc, t-Butyloxycarbonyl), Boc-Q-A-R-AMC, Boc-V-L-K-AMC Suc-A-A-F-AMC (Suc, Succinyl), Suc-A-A-P-F-AMC, Suc-L-Y-AMC, MeOSuc-A-A-P-V-AMC (MeOSuc, 3-Methoxysuccinyl), Z-G-G-L-AMC and Z-V-K-M-AMC. Assays were performed at 37°C in 96-well black microplates in a total volume of 100 µl. Parasite extracts (1–3 µg) or E/S products (0.05–1 µg) were pre-incubated for 10 min in 150 mM Tris-HCl, pH 8.0, containing 10 µM E64, 1 mM EDTA in the presence or absence of 0.5 mM of the serine protease inhibitors, Pefabloc SC and PMSF. E64 was included routinely in extract preparations in order to inhibit Clan CA cysteine protease activity that is present in the life-stages examined [30] (link), [39] (link), [40] (link). Hydrolysis of substrate was measured continuously using an Infinite M1000 microplate reader (Tecan) at excitation and emission wavelengths of 360 and 465 nm, respectively. All measurements were performed in triplicate and results normalized to protein concentration.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!